{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:53:32Z","timestamp":1788666812264,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jneuroim.2007.10.018","type":"journal-article","created":{"date-parts":[[2008,2,11]],"date-time":"2008-02-11T07:05:37Z","timestamp":1202713537000},"page":"96-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis"],"prefix":"10.1016","volume":"195","author":[{"given":"Fredrik R.","family":"Romi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Luckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.10.018_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.153.1.1","article-title":"Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering","volume":"153","author":"Borges","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0404.1995.tb00432.x","article-title":"Associated autoimmune diseases in myasthenia gravis. A population-based study","volume":"91","author":"Christensen","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib3","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1093\/emboj\/16.16.4951","article-title":"Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle","volume":"16","author":"Fuhrer","year":"1997","journal-title":"EMBO"},{"key":"10.1016\/j.jneuroim.2007.10.018_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib5","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1073\/pnas.93.12.5985","article-title":"Substrate-bound agrin induces expression of acetylcholine receptor epsilon-subunit gene in cultured mammalian muscle cells","volume":"93","author":"Jones","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.jneuroim.2007.10.018_bib6","first-page":"409","article-title":"Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis","volume":"16","author":"Kotajima","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-5728(95)00169-7","article-title":"Modulation of acetylcholine receptor function in TE671 (rhabdomyocyosarcoma) cells by non-AchR ligands: possible relevance to seronegative myasthenia gravis","volume":"64","author":"Li","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1212\/WNL.51.4.933-a","article-title":"Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975 classical article","volume":"51","author":"Lindstr\u00f8m","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.10.018_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1083\/jcb.141.3.715","article-title":"Agrin can mediate acetylcholine receptor gene expression by aggregation of muscle-derived neuregulins","volume":"141","author":"Meier","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2007.10.018_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2005.01137.x","article-title":"Seronegative myasthenia gravis: disease severity and prognosis","volume":"12","author":"Romi","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib13","series-title":"Guidebook to the Extracellular Matrix and Adhesion Proteins","first-page":"503","article-title":"ECM proteinases","author":"Sternlicht","year":"1999"},{"key":"10.1016\/j.jneuroim.2007.10.018_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00000441-200601000-00004","article-title":"High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study","volume":"331","author":"Sthoeger","year":"2006","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.0.CO;2-K","article-title":"Matrix metalloproteinase-3 removes agrin from synaptic basal lamina","volume":"43","author":"VanSaun","year":"2000","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1023\/B:NEUR.0000021907.68461.9c","article-title":"Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice","volume":"32","author":"Vansaun","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0952-7915(93)90105-2","article-title":"Myasthenia gravis","volume":"5","author":"Wilcox","year":"1993","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2007.10.018_bib18","first-page":"2329","article-title":"Elevated plasma stromelysin levels in arthritis","volume":"21","author":"Zucker","year":"1994","journal-title":"J. Rheumatol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:10:18Z","timestamp":1759047018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0165572807003669"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.10.018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}